| Item Type | Name |
|
Concept
|
Acute Disease
|
|
Concept
|
Acetates
|
|
Concept
|
Adenocarcinoma
|
|
Concept
|
Affect
|
|
Concept
|
Age Factors
|
|
Concept
|
Activities of Daily Living
|
|
Concept
|
Adenosine
|
|
Concept
|
Anti-Infective Agents
|
|
Concept
|
Antigen-Antibody Complex
|
|
Concept
|
Antigens, Neoplasm
|
|
Concept
|
Amyloidosis
|
|
Concept
|
Antibiotics, Antineoplastic
|
|
Concept
|
Antibodies, Neoplasm
|
|
Concept
|
Aldehyde Reductase
|
|
Concept
|
Asparagine
|
|
Concept
|
Aminoglycosides
|
|
Concept
|
Anemia, Refractory, with Excess of Blasts
|
|
Concept
|
Adaptation, Psychological
|
|
Concept
|
Breast Neoplasms
|
|
Concept
|
Alkylating Agents
|
|
Concept
|
Amino Acid Sequence
|
|
Concept
|
Agranulocytosis
|
|
Concept
|
Acyclovir
|
|
Concept
|
Aerosols
|
|
Concept
|
Antigens, Differentiation
|
|
Concept
|
Antineoplastic Agents
|
|
Concept
|
Busulfan
|
|
Concept
|
Aminopyridines
|
|
Concept
|
Amsacrine
|
|
Concept
|
Animals
|
|
Concept
|
Anticoagulants
|
|
Concept
|
Antifungal Agents
|
|
Concept
|
Anemia, Sideroblastic
|
|
Concept
|
Antimetabolites, Antineoplastic
|
|
Concept
|
Antineoplastic Combined Chemotherapy Protocols
|
|
Concept
|
Antiviral Agents
|
|
Concept
|
Anemia, Refractory
|
|
Concept
|
Chromosome Banding
|
|
Concept
|
Chromosomes, Human, Pair 11
|
|
Concept
|
Chromosomes, Human, Pair 2
|
|
Concept
|
Chromosomes, Human, Pair 6
|
|
Concept
|
Arabinofuranosylcytosine Triphosphate
|
|
Concept
|
Amphotericin B
|
|
Concept
|
Analysis of Variance
|
|
Concept
|
Antibodies, Monoclonal
|
|
Concept
|
Chromosomes, Human, Pair 8
|
|
Concept
|
Feeding and Eating Disorders
|
|
Concept
|
Cyclosporins
|
|
Concept
|
Antigens, Differentiation, B-Lymphocyte
|
|
Concept
|
Histocompatibility Antigens Class II
|
|
Concept
|
Antimetabolites
|
|
Concept
|
Arabinonucleosides
|
|
Concept
|
B-Lymphocytes
|
|
Concept
|
Base Sequence
|
|
Concept
|
Benzamides
|
|
Concept
|
Cell Count
|
|
Concept
|
Benzene
|
|
Concept
|
Aspartate Carbamoyltransferase
|
|
Concept
|
Aspartic Acid
|
|
Concept
|
Atrial Fibrillation
|
|
Concept
|
Azacitidine
|
|
Concept
|
Binding Sites
|
|
Concept
|
Blood Glucose
|
|
Concept
|
Blast Crisis
|
|
Concept
|
Benzhydryl Compounds
|
|
Concept
|
Biopsy, Needle
|
|
Concept
|
Bleomycin
|
|
Concept
|
Biopsy
|
|
Concept
|
Body Weight
|
|
Concept
|
Butadienes
|
|
Concept
|
Cannabis
|
|
Concept
|
Borohydrides
|
|
Concept
|
Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing)
|
|
Concept
|
Cattle
|
|
Concept
|
Cell Division
|
|
Concept
|
Cell Separation
|
|
Concept
|
Breast Feeding
|
|
Concept
|
Bromodeoxyuridine
|
|
Concept
|
Chromosomes, Human, Pair 1
|
|
Concept
|
Chromosomes, Human, Pair 15
|
|
Concept
|
Chromosomes, Human, Pair 21
|
|
Concept
|
Chromosomes, Human, Pair 3
|
|
Concept
|
Chromosomes, Human, 4-5
|
|
Concept
|
Cell Transformation, Viral
|
|
Concept
|
Centromere
|
|
Concept
|
Carcinogens
|
|
Concept
|
Flavonoids
|
|
Concept
|
Chromosomes, Human, Pair 12
|
|
Concept
|
Chromosomes, Human, Pair 14
|
|
Concept
|
Chromosomes, Human, 6-12 and X
|
|
Concept
|
Coma
|
|
Concept
|
Cell Transformation, Neoplastic
|
|
Concept
|
Child Development
|
|
Concept
|
Chromosome Deletion
|
|
Concept
|
Chromosomes, Human, Pair 13
|
|
Concept
|
Chromosomes, Human, Pair 22
|
|
Concept
|
Chromosomes, Human, Pair 4
|
|
Concept
|
Codon
|
|
Concept
|
Burkitt Lymphoma
|
|
Concept
|
Gastrointestinal Agents
|
|
Concept
|
Gastrointestinal Diseases
|
|
Concept
|
Genes, Immunoglobulin
|
|
Concept
|
Chromosomes, Human, Pair 5
|
|
Concept
|
Chromosomes, Human, Pair 7
|
|
Concept
|
Chromosomes, Human, 13-15
|
|
Concept
|
Leucovorin
|
|
Concept
|
C-Reactive Protein
|
|
Concept
|
Glucosephosphate Dehydrogenase
|
|
Concept
|
Graft vs Host Disease
|
|
Concept
|
Cholesterol
|
|
Concept
|
Chromosomes, Human, Pair 20
|
|
Concept
|
Chromosomes, Human, 16-18
|
|
Concept
|
Chromosomes, Human, 21-22 and Y
|
|
Concept
|
Hematocrit
|
|
Concept
|
Hepatic Veno-Occlusive Disease
|
|
Concept
|
Colony-Forming Units Assay
|
|
Concept
|
Colony-Stimulating Factors
|
|
Concept
|
Copper
|
|
Concept
|
Demography
|
|
Concept
|
Herpes Zoster
|
|
Concept
|
Cytochalasin B
|
|
Concept
|
Dinitrobenzenes
|
|
Concept
|
Cytochalasins
|
|
Concept
|
Cytological Techniques
|
|
Concept
|
Dermatomycoses
|
|
Concept
|
Dexamethasone
|
|
Concept
|
Drug Synergism
|
|
Concept
|
Immunosuppressive Agents
|
|
Concept
|
Infusion Pumps
|
|
Concept
|
Interleukin-2
|
|
Concept
|
Interleukins
|
|
Concept
|
Iron
|
|
Concept
|
Leukemia, Erythroblastic, Acute
|
|
Concept
|
Cytomegalovirus Infections
|
|
Concept
|
DNA, Bacterial
|
|
Concept
|
Cause of Death
|
|
Concept
|
Child, Preschool
|
|
Concept
|
DNA, Neoplasm
|
|
Concept
|
Dogs
|
|
Concept
|
Drug Hypersensitivity
|
|
Concept
|
Cyclophosphamide
|
|
Concept
|
Daunorubicin
|
|
Concept
|
Europe
|
|
Concept
|
Genes, Regulator
|
|
Concept
|
Genital Neoplasms, Male
|
|
Concept
|
Glucocorticoids
|
|
Concept
|
Glycoproteins
|
|
Concept
|
Graft Survival
|
|
Concept
|
Hemangioma
|
|
Concept
|
Hematology
|
|
Concept
|
Emotions
|
|
Concept
|
Histamine H2 Antagonists
|
|
Concept
|
Enzyme Inhibitors
|
|
Concept
|
Leukemia
|
|
Concept
|
Leukemia, Lymphoid
|
|
Concept
|
Listeriosis
|
|
Concept
|
London
|
|
Concept
|
Immunologic Factors
|
|
Concept
|
Chromatography, High Pressure Liquid
|
|
Concept
|
Chromosomes, Human, Pair 17
|
|
Concept
|
Chromosomes, Human, Pair 9
|
|
Concept
|
Chromosomes, Human, 19-20
|
|
Concept
|
Amifostine
|
|
Concept
|
Etoposide
|
|
Concept
|
Expert Testimony
|
|
Concept
|
Cross-Sectional Studies
|
|
Concept
|
Cytarabine
|
|
Concept
|
DNA
|
|
Concept
|
DNA Topoisomerases, Type II
|
|
Concept
|
Double-Blind Method
|
|
Concept
|
Diphtheria Toxin
|
|
Concept
|
Face
|
|
Concept
|
Infant, Newborn
|
|
Concept
|
Interferons
|
|
Concept
|
Intubation
|
|
Concept
|
Chromosome Inversion
|
|
Concept
|
Emergency Medical Technicians
|
|
Concept
|
Methyltransferases
|
|
Concept
|
Microtubule-Associated Proteins
|
|
Concept
|
Multienzyme Complexes
|
|
Concept
|
Genes, Dominant
|
|
Concept
|
Glomerular Filtration Rate
|
|
Concept
|
Feasibility Studies
|
|
Concept
|
Fingers
|
|
Concept
|
Neoplasms, Radiation-Induced
|
|
Concept
|
Terminology as Topic
|
|
Concept
|
Karyotyping
|
|
Concept
|
Killer Cells, Natural
|
|
Concept
|
Graft Rejection
|
|
Concept
|
Harringtonines
|
|
Concept
|
Formaldehyde
|
|
Concept
|
DNA (Cytosine-5-)-Methyltransferases
|
|
Concept
|
Obesity
|
|
Concept
|
Oncogenes
|
|
Concept
|
Gingivitis
|
|
Concept
|
T-Lymphocytes, Helper-Inducer
|
|
Concept
|
Histocytochemistry
|
|
Concept
|
Electroencephalography
|
|
Concept
|
Dose-Response Relationship, Drug
|
|
Concept
|
Hydrocarbons, Chlorinated
|
|
Concept
|
Laryngeal Neoplasms
|
|
Concept
|
Leukocytosis
|
|
Concept
|
Life Expectancy
|
|
Concept
|
Lipoproteins
|
|
Concept
|
Liposomes
|
|
Concept
|
Immune Tolerance
|
|
Concept
|
Immunoblastic Lymphadenopathy
|
|
Concept
|
Immunoglobulin Heavy Chains
|
|
Concept
|
Immunotherapy
|
|
Concept
|
Environmental Exposure
|
|
Concept
|
Eosinophils
|
|
Concept
|
Herpesvirus 4, Human
|
|
Concept
|
Histocompatibility Testing
|
|
Concept
|
Erythropoiesis
|
|
Concept
|
Escherichia coli
|
|
Concept
|
Hydroxamic Acids
|
|
Concept
|
Flow Cytometry
|
|
Concept
|
Infusions, Intravenous
|
|
Concept
|
Injections, Spinal
|
|
Concept
|
Interleukin-1
|
|
Concept
|
Focal Infection, Dental
|
|
Concept
|
Folic Acid Antagonists
|
|
Concept
|
Gene Amplification
|
|
Concept
|
Glutathione
|
|
Concept
|
Granulocytes
|
|
Concept
|
Length of Stay
|
|
Concept
|
Lepidoptera
|
|
Concept
|
Leukocytes, Mononuclear
|
|
Concept
|
Gastrointestinal Hemorrhage
|
|
Concept
|
Lymphocyte Depletion
|
|
Concept
|
Ischemia
|
|
Concept
|
Mechlorethamine
|
|
Concept
|
Lactation
|
|
Concept
|
Hydrazines
|
|
Concept
|
Hydroxycholesterols
|
|
Concept
|
Microfilament Proteins
|
|
Concept
|
Muscle Cramp
|
|
Concept
|
Pilot Projects
|
|
Concept
|
Methylnitronitrosoguanidine
|
|
Concept
|
Models, Genetic
|
|
Concept
|
Neutropenia
|
|
Concept
|
Markov Chains
|
|
Concept
|
Medical Audit
|
|
Concept
|
Esophageal Cyst
|
|
Concept
|
European Union
|
|
Concept
|
Illinois
|
|
Concept
|
Immunization, Secondary
|
|
Concept
|
Immunoglobulin Isotypes
|
|
Concept
|
Immunoglobulin Variable Region
|
|
Concept
|
Opportunistic Infections
|
|
Concept
|
Optical Rotation
|
|
Concept
|
Molecular Sequence Data
|
|
Concept
|
Molecular Weight
|
|
Concept
|
Palliative Care
|
|
Concept
|
Methotrexate
|
|
Concept
|
Mevalonic Acid
|
|
Concept
|
Mice, Inbred C57BL
|
|
Concept
|
Mitogens
|
|
Concept
|
Mitoxantrone
|
|
Concept
|
Morbidity
|
|
Concept
|
Patents as Topic
|
|
Concept
|
Interleukin-3
|
|
Concept
|
Isocitrate Dehydrogenase
|
|
Concept
|
Isoleucine
|
|
Concept
|
Kidney Function Tests
|
|
Concept
|
Neutrophils
|
|
Concept
|
Naphthalenes
|
|
Concept
|
Philadelphia Chromosome
|
|
Concept
|
Nucleic Acid Conformation
|
|
Concept
|
Ovarian Neoplasms
|
|
Concept
|
Liposarcoma
|
|
Concept
|
Lung Neoplasms
|
|
Concept
|
Mediastinal Neoplasms
|
|
Concept
|
Megakaryocytes
|
|
Concept
|
Melphalan
|
|
Concept
|
Microscopy, Electron
|
|
Concept
|
Periodontal Diseases
|
|
Concept
|
Photochemistry
|
|
Concept
|
Practice Patterns, Physicians'
|
|
Concept
|
Mouth Mucosa
|
|
Concept
|
Oxygen
|
|
Concept
|
Patient Care Team
|
|
Concept
|
Feeding Behavior
|
|
Concept
|
Probability
|
|
Concept
|
Prednisone
|
|
Concept
|
Preoperative Care
|
|
Concept
|
Prescription Fees
|
|
Concept
|
Thoracostomy
|
|
Concept
|
Purine Nucleosides
|
|
Concept
|
Histone Deacetylases
|
|
Concept
|
HLA Antigens
|
|
Concept
|
Hodgkin Disease
|
|
Concept
|
Radiation Injuries
|
|
Concept
|
Receptors, Fc
|
|
Concept
|
Rectal Neoplasms
|
|
Concept
|
Recurrence
|
|
Concept
|
Regression Analysis
|
|
Concept
|
Hematologic Agents
|
|
Concept
|
Radiation-Sensitizing Agents
|
|
Concept
|
Registries
|
|
Concept
|
Risk Factors
|
|
Concept
|
RNA, Neoplasm
|
|
Concept
|
Rosette Formation
|
|
Concept
|
Rubber
|
|
Concept
|
Quality of Life
|
|
Concept
|
Receptors, Immunologic
|
|
Concept
|
Interferon-gamma
|
|
Concept
|
Intestinal Absorption
|
|
Concept
|
Social Support
|
|
Concept
|
Respiratory Tract Infections
|
|
Concept
|
Cohort Studies
|
|
Concept
|
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor
|
|
Concept
|
RNA Probes
|
|
Concept
|
Genes, ras
|
|
Concept
|
Regulatory Sequences, Nucleic Acid
|
|
Concept
|
Polymorphism, Restriction Fragment Length
|
|
Concept
|
Ribonucleoproteins
|
|
Concept
|
Leukemia, B-Cell
|
|
Concept
|
Interleukin-6
|
|
Concept
|
Stomatitis
|
|
Concept
|
Risk
|
|
Concept
|
RNA
|
|
Concept
|
Sensitivity and Specificity
|
|
Concept
|
Skin Diseases, Infectious
|
|
Concept
|
Social Environment
|
|
Concept
|
Homeostasis
|
|
Concept
|
Societies, Medical
|
|
Concept
|
Humans
|
|
Concept
|
Leukemia, Radiation-Induced
|
|
Concept
|
Leukocyte Count
|
|
Concept
|
Leukopenia
|
|
Concept
|
Complement C1q
|
|
Concept
|
Body Mass Index
|
|
Concept
|
Incidence
|
|
Concept
|
Cluster Analysis
|
|
Concept
|
Bone Marrow Transplantation
|
|
Concept
|
Single-Blind Method
|
|
Concept
|
Styrenes
|
|
Concept
|
Ticlopidine
|
|
Concept
|
Tooth Extraction
|
|
Concept
|
Tretinoin
|
|
Concept
|
Thalidomide
|
|
Concept
|
Statistics as Topic
|
|
Concept
|
Tritium
|
|
Concept
|
Interferon Type I
|
|
Concept
|
International Agencies
|
|
Concept
|
Teniposide
|
|
Concept
|
Genes, abl
|
|
Concept
|
United States
|
|
Concept
|
United States Food and Drug Administration
|
|
Concept
|
Syndrome
|
|
Concept
|
Interleukin-9
|
|
Concept
|
Trisomy
|
|
Concept
|
Tumor Stem Cell Assay
|
|
Concept
|
Tongue Diseases
|
|
Concept
|
Clinical Trials, Phase I as Topic
|
|
Concept
|
Voluntary Health Agencies
|
|
Concept
|
Warfarin
|
|
Concept
|
Silicates
|
|
Concept
|
Ki-1 Antigen
|
|
Concept
|
Kidney Failure, Chronic
|
|
Concept
|
Ultraviolet Rays
|
|
Concept
|
Germ-Line Mutation
|
|
Concept
|
Multicenter Studies as Topic
|
|
Concept
|
Leukemia, Lymphocytic, Chronic, B-Cell
|
|
Concept
|
Leukemia, Myeloid, Accelerated Phase
|
|
Concept
|
Geriatric Assessment
|
|
Concept
|
Mercaptopurine
|
|
Concept
|
Leiomyosarcoma
|
|
Concept
|
Leukemia, Myeloid
|
|
Concept
|
Lung
|
|
Concept
|
Lovastatin
|
|
Concept
|
Lymphocytosis
|
|
Concept
|
Lymphoma, Follicular
|
|
Concept
|
Endodermal Sinus Tumor
|
|
Concept
|
Hematopoietic Stem Cell Transplantation
|
|
Concept
|
Oncogene Proteins, Fusion
|
|
Concept
|
Proportional Hazards Models
|
|
Concept
|
Randomized Controlled Trials as Topic
|
|
Concept
|
Risk Assessment
|
|
Concept
|
CD56 Antigen
|
|
Concept
|
Disease Management
|
|
Concept
|
Myeloablative Agonists
|
|
Concept
|
Reverse Transcriptase Polymerase Chain Reaction
|
|
Concept
|
Gene Duplication
|
|
Concept
|
Herpesvirus 3, Human
|
|
Concept
|
Vidarabine
|
|
Concept
|
S Phase
|
|
Concept
|
Treatment Refusal
|
|
Concept
|
Central Nervous System Neoplasms
|
|
Concept
|
Genes, BRCA2
|
|
Concept
|
Cryopreservation
|
|
Concept
|
Southwestern United States
|
|
Concept
|
Antigens, Differentiation, Myelomonocytic
|
|
Concept
|
Prevalence
|
|
Concept
|
Genes, Tumor Suppressor
|
|
Concept
|
Genes, Wilms Tumor
|
|
Concept
|
Metabolic Clearance Rate
|
|
Concept
|
Immunocompromised Host
|
|
Concept
|
Receptors, Interleukin-2
|
|
Concept
|
Leukemia, Prolymphocytic
|
|
Concept
|
Leukemia, Myelomonocytic, Acute
|
|
Concept
|
Antigens, CD
|
|
Concept
|
Ganciclovir
|
|
Concept
|
Drug Costs
|
|
Concept
|
NAD(P)H Dehydrogenase (Quinone)
|
|
Concept
|
Lymph Nodes
|
|
Concept
|
Lymphoma
|
|
Concept
|
Mastectomy
|
|
Concept
|
Mortality
|
|
Concept
|
Multiple Myeloma
|
|
Concept
|
Gene Rearrangement, B-Lymphocyte, Heavy Chain
|
|
Concept
|
DNA Probes
|
|
Concept
|
Leukemia, Myeloid, Acute
|
|
Concept
|
Interleukin-4
|
|
Concept
|
Chi-Square Distribution
|
|
Concept
|
Receptors, Granulocyte Colony-Stimulating Factor
|
|
Concept
|
Comorbidity
|
|
Concept
|
Stem Cell Transplantation
|
|
Concept
|
Foscarnet
|
|
Concept
|
Clinical Trials, Phase II as Topic
|
|
Concept
|
Occupational Exposure
|
|
Concept
|
Hematopoietic Cell Growth Factors
|
|
Concept
|
Tacrolimus
|
|
Concept
|
Case-Control Studies
|
|
Concept
|
Proto-Oncogene Proteins c-abl
|
|
Concept
|
Hypopigmentation
|
|
Concept
|
Age Distribution
|
|
Concept
|
Community-Acquired Infections
|
|
Concept
|
Medical Oncology
|
|
Concept
|
Mental Health
|
|
Concept
|
Methylation
|
|
Concept
|
Paraffin Embedding
|
|
Concept
|
Treatment Outcome
|
|
Concept
|
Neoplasm Metastasis
|
|
Concept
|
Neoplasm Recurrence, Local
|
|
Concept
|
Ubiquitin Thiolesterase
|
|
Concept
|
Tissue Fixation
|
|
Concept
|
Point Mutation
|
|
Concept
|
Interferon-alpha
|
|
Concept
|
Antibodies, Bispecific
|
|
Concept
|
Health Care Costs
|
|
Concept
|
Gene Deletion
|
|
Concept
|
Sequence Deletion
|
|
Concept
|
Mice, Knockout
|
|
Concept
|
DNA, Complementary
|
|
Concept
|
Cell Proliferation
|
|
Concept
|
Patient-Centered Care
|
|
Concept
|
Antigens, CD34
|
|
Concept
|
Disease Progression
|
|
Concept
|
Telomerase
|
|
Concept
|
Transplantation Conditioning
|
|
Concept
|
Inhibitor of Apoptosis Proteins
|
|
Concept
|
Simvastatin
|
|
Concept
|
Sepsis
|
|
Concept
|
Antineoplastic Agents, Alkylating
|
|
Concept
|
Antigens, CD19
|
|
Concept
|
Angiogenesis Inhibitors
|
|
Concept
|
Staurosporine
|
|
Concept
|
Fanconi Anemia Complementation Group D2 Protein
|
|
Concept
|
Receptor Protein-Tyrosine Kinases
|
|
Concept
|
Mutation, Missense
|
|
Concept
|
Cross-Over Studies
|
|
Concept
|
Lymphocyte Count
|
|
Concept
|
Immunoconjugates
|
|
Concept
|
Osteolysis
|
|
Concept
|
CpG Islands
|
|
Concept
|
Lipopolysaccharide Receptors
|
|
Concept
|
Bone Marrow Neoplasms
|
|
Concept
|
Case Management
|
|
Concept
|
Models, Econometric
|
|
Concept
|
Pentose Phosphate Pathway
|
|
Concept
|
Cladribine
|
|
Concept
|
In Situ Hybridization, Fluorescence
|
|
Concept
|
Watchful Waiting
|
|
Concept
|
Chromosomes, Artificial, Human
|
|
Concept
|
Fatal Outcome
|
|
Concept
|
Ontario
|
|
Concept
|
Peripheral Blood Stem Cell Transplantation
|
|
Concept
|
Lymphatic Vessels
|
|
Concept
|
Consensus
|
|
Concept
|
History, 21st Century
|
|
Concept
|
PubMed
|
|
Concept
|
Chromatin Assembly and Disassembly
|
|
Concept
|
Granulocyte Precursor Cells
|
|
Concept
|
Microarray Analysis
|
|
Concept
|
Proto-Oncogene Proteins c-mdm2
|
|
Concept
|
Fanconi Anemia Complementation Group A Protein
|
|
Concept
|
Carcinoma, Small Cell
|
|
Concept
|
Proto-Oncogene Proteins c-bcl-2
|
|
Concept
|
Area Under Curve
|
|
Concept
|
Trinucleotide Repeats
|
|
Concept
|
Anthracyclines
|
|
Concept
|
Proto-Oncogene Proteins c-kit
|
|
Concept
|
Patient Participation
|
|
Concept
|
Oligonucleotide Array Sequence Analysis
|
|
Concept
|
Quality-Adjusted Life Years
|
|
Concept
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors
|
|
Concept
|
Receptors, Thrombopoietin
|
|
Concept
|
Mitogen-Activated Protein Kinase Kinases
|
|
Concept
|
Evidence-Based Medicine
|
|
Concept
|
Genes, BRCA1
|
|
Concept
|
Styrene
|
|
Concept
|
Catalytic Domain
|
|
Concept
|
Interdisciplinary Communication
|
|
Concept
|
Sarcoma, Myeloid
|
|
Concept
|
Cyclin-Dependent Kinase Inhibitor p21
|
|
Concept
|
Farnesyltranstransferase
|
|
Concept
|
Peritoneal Dialysis, Continuous Ambulatory
|
|
Concept
|
Peritonitis
|
|
Concept
|
Physicians
|
|
Concept
|
Platelet Count
|
|
Concept
|
Polyethylene Glycols
|
|
Concept
|
Singlet Oxygen
|
|
Concept
|
Pleural Effusion
|
|
Concept
|
Postoperative Complications
|
|
Concept
|
Mice
|
|
Concept
|
Pyrazoles
|
|
Concept
|
Fanconi Anemia Complementation Group G Protein
|
|
Concept
|
Surveys and Questionnaires
|
|
Concept
|
Radiation-Protective Agents
|
|
Concept
|
Respiratory Tract Neoplasms
|
|
Concept
|
Scrotum
|
|
Concept
|
Severity of Illness Index
|
|
Concept
|
Research Design
|
|
Concept
|
RNA, Messenger
|
|
Concept
|
Mastocytosis, Systemic
|
|
Concept
|
Sulfonamides
|
|
Concept
|
Thrombopoietin
|
|
Concept
|
Monoterpenes
|
|
Concept
|
Receptors, Vascular Endothelial Growth Factor
|
|
Concept
|
Chimerism
|
|
Concept
|
Dioxygenases
|
|
Concept
|
Preoperative Period
|
|
Concept
|
HEK293 Cells
|
|
Concept
|
Proto-Oncogene Proteins c-cbl
|
|
Concept
|
GATA1 Transcription Factor
|
|
Concept
|
Trauma Centers
|
|
Concept
|
ADP-ribosyl Cyclase 1
|
|
Concept
|
Inflammatory Breast Neoplasms
|
|
Concept
|
Antibodies, Monoclonal, Humanized
|
|
Concept
|
Sex Factors
|
|
Concept
|
Spleen
|
|
Concept
|
Stereoisomerism
|
|
Concept
|
Vincristine
|
|
Concept
|
Adaptor Proteins, Signal Transducing
|
|
Concept
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
|
|
Concept
|
Television
|
|
Concept
|
Temperature
|
|
Concept
|
Blotting, Western
|
|
Concept
|
Protein Interaction Domains and Motifs
|
|
Concept
|
Tumor Lysis Syndrome
|
|
Concept
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
|
|
Concept
|
Leukemia, Promyelocytic, Acute
|
|
Concept
|
Cyclin-Dependent Kinase Inhibitor p15
|
|
Concept
|
NK Cell Lectin-Like Receptor Subfamily K
|
|
Concept
|
Life Tables
|
|
Concept
|
Multivariate Analysis
|
|
Concept
|
Logistic Models
|
|
Concept
|
Survival Analysis
|
|
Concept
|
Genes, fms
|
|
Concept
|
Lewis X Antigen
|
|
Concept
|
Genes, myc
|
|
Concept
|
CD4-CD8 Ratio
|
|
Concept
|
Drug Monitoring
|
|
Concept
|
Caregivers
|
|
Concept
|
Vinblastine
|
|
Concept
|
Blotting, Southern
|
|
Concept
|
Blotting, Northern
|
|
Concept
|
Reproducibility of Results
|
|
Concept
|
Treatment Failure
|
|
Concept
|
Leukemia-Lymphoma, Adult T-Cell
|
|
Concept
|
Leukemia, Myeloid, Chronic-Phase
|
|
Concept
|
Abnormal Karyotype
|
|
Concept
|
Gene Expression Regulation, Leukemic
|
|
Concept
|
Survival Rate
|
|
Concept
|
Confidence Intervals
|
|
Concept
|
Fusion Proteins, bcr-abl
|
|
Concept
|
Lymphocyte Subsets
|
|
Concept
|
Polymerase Chain Reaction
|
|
Concept
|
Genes, p53
|
|
Concept
|
Granulocyte Colony-Stimulating Factor
|
|
Concept
|
Proto-Oncogene Proteins p21(ras)
|
|
Concept
|
Zinc Fingers
|
|
Concept
|
Patient Selection
|
|
Concept
|
CD2 Antigens
|
|
Concept
|
Lymphoma, T-Cell
|
|
Concept
|
CD13 Antigens
|
|
Concept
|
CD3 Complex
|
|
Concept
|
Leukemic Infiltration
|
|
Concept
|
Clinical Trials, Phase III as Topic
|
|
Concept
|
Investigational New Drug Application
|
|
Concept
|
DNA Methylation
|
|
Concept
|
GTP-Binding Proteins
|
|
Concept
|
Karnofsky Performance Status
|
|
Concept
|
Dental Care for Chronically Ill
|
|
Concept
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma
|
|
Concept
|
Graft vs Leukemia Effect
|
|
Concept
|
Myeloid Progenitor Cells
|
|
Concept
|
Receptors, Natural Killer Cell
|
|
Concept
|
Homeodomain Proteins
|
|
Concept
|
Statistics, Nonparametric
|
|
Concept
|
Models, Economic
|
|
Concept
|
Microsatellite Repeats
|
|
Concept
|
Cell Lineage
|
|
Concept
|
Hematologic Neoplasms
|
|
Concept
|
Chemical and Drug Induced Liver Injury
|
|
Concept
|
Histone Deacetylase Inhibitors
|
|
Concept
|
Ideal Body Weight
|
|
Concept
|
O(6)-Methylguanine-DNA Methyltransferase
|
|
Concept
|
Tandem Repeat Sequences
|
|
Concept
|
Heterogeneous-Nuclear Ribonucleoprotein K
|
|
Concept
|
History, 20th Century
|
|
Concept
|
Drug Resistance, Viral
|
|
Concept
|
STAT5 Transcription Factor
|
|
Concept
|
Acute Kidney Injury
|
|
Concept
|
Janus Kinase 2
|
|
Concept
|
Nanoparticles
|
|
Concept
|
Genome-Wide Association Study
|
|
Concept
|
Secondary Prevention
|
|
Concept
|
Precision Medicine
|
|
Concept
|
Multiplex Polymerase Chain Reaction
|
|
Concept
|
RNA, Small Interfering
|
|
Concept
|
Cord Blood Stem Cell Transplantation
|
|
Concept
|
Antibodies, Monoclonal, Murine-Derived
|
|
Concept
|
Telomere Homeostasis
|
|
Concept
|
Depsipeptides
|
|
Concept
|
Suppressor of Cytokine Signaling Proteins
|
|
Concept
|
Ikaros Transcription Factor
|
|
Concept
|
ZAP-70 Protein-Tyrosine Kinase
|
|
Concept
|
Myeloid-Lymphoid Leukemia Protein
|
|
Concept
|
fms-Like Tyrosine Kinase 3
|
|
Concept
|
Kaplan-Meier Estimate
|
|
Concept
|
Healthcare Disparities
|
|
Concept
|
Drug Discovery
|
|
Concept
|
Intention to Treat Analysis
|
|
Concept
|
Epigenomics
|
|
Concept
|
Topoisomerase II Inhibitors
|
|
Concept
|
Aluminum Silicates
|
|
Concept
|
Anti-Bacterial Agents
|
|
Concept
|
Immunotoxins
|
|
Concept
|
Antineoplastic Agents, Phytogenic
|
|
Concept
|
Blood Cell Count
|
|
Concept
|
Body Surface Area
|
|
Concept
|
Bone Resorption
|
|
Concept
|
Brain Neoplasms
|
|
Concept
|
Carbolines
|
|
Concept
|
Chlorambucil
|
|
Concept
|
Chromatin
|
|
Concept
|
Chromosome Aberrations
|
|
Concept
|
Chromosomes, Human
|
|
Concept
|
Chromosomes, Human, Pair 16
|
|
Concept
|
Clinical Trials as Topic
|
|
Concept
|
Consensus Development Conferences as Topic
|
|
Concept
|
Cytosine
|
|
Concept
|
Data Collection
|
|
Concept
|
Data Interpretation, Statistical
|
|
Concept
|
Deoxycytidine
|
|
Concept
|
Drug Eruptions
|
|
Concept
|
Doxorubicin
|
|
Concept
|
Electrochemistry
|
|
Concept
|
Esophageal Neoplasms
|
|
Concept
|
Fluorescent Dyes
|
|
Concept
|
Follow-Up Studies
|
|
Concept
|
Genetic Testing
|
|
Concept
|
Glucose
|
|
Concept
|
Haemophilus influenzae
|
|
Concept
|
Health Status
|
|
Concept
|
Hemorrhage
|
|
Concept
|
Histiocytes
|
|
Concept
|
Hypercalcemia
|
|
Concept
|
Injections
|
|
Concept
|
Injections, Subcutaneous
|
|
Concept
|
Laparotomy
|
|
Concept
|
Leukemia, Hairy Cell
|
|
Concept
|
Leukemia, Monocytic, Acute
|
|
Concept
|
Liver Diseases
|
|
Concept
|
Longitudinal Studies
|
|
Concept
|
Lymphocyte Activation
|
|
Concept
|
Lymphocytes
|
|
Concept
|
Lymphoma, Non-Hodgkin
|
|
Concept
|
Mitomycins
|
|
Concept
|
Models, Biological
|
|
Concept
|
Monocytes
|
|
Concept
|
Monosomy
|
|
Concept
|
Oxides
|
|
Concept
|
Paramyxoviridae
|
|
Concept
|
Patient Compliance
|
|
Concept
|
Personality Assessment
|
|
Concept
|
Predictive Value of Tests
|
|
Concept
|
Procarbazine
|
|
Concept
|
Prospective Studies
|
|
Concept
|
Histone-Lysine N-Methyltransferase
|
|
Concept
|
Proto-Oncogenes
|
|
Concept
|
Purine-Nucleoside Phosphorylase
|
|
Concept
|
Receptors, Antigen, T-Cell
|
|
Concept
|
Retrospective Studies
|
|
Concept
|
Ricin
|
|
Concept
|
Staining and Labeling
|
|
Concept
|
T-Lymphocytes
|
|
Concept
|
Terpenes
|
|
Concept
|
Translocation, Genetic
|
|
Concept
|
World Health Organization
|
|
Concept
|
Idarubicin
|
|
Concept
|
Leukemia, T-Cell
|
|
Concept
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
|
|
Concept
|
Interleukin-5
|
|
Concept
|
Immunophenotyping
|
|
Concept
|
Granulocyte-Macrophage Colony-Stimulating Factor
|
|
Concept
|
Cytokines
|
|
Concept
|
Mutagenesis, Insertional
|
|
Concept
|
Oligonucleotides, Antisense
|
|
Concept
|
Mitomycin
|
|
Concept
|
Cost of Illness
|
|
Concept
|
DNA Primers
|
|
Concept
|
Neoplasm, Residual
|
|
Concept
|
Disease-Free Survival
|
|
Concept
|
Chromosome Breakage
|
|
Concept
|
Genetic Predisposition to Disease
|
|
Concept
|
Polymorphism, Single Nucleotide
|
|
Concept
|
Cytogenetic Analysis
|
|
Concept
|
Hyperuricemia
|
|
Concept
|
MicroRNAs
|
|
Concept
|
Cyclin-Dependent Kinase 9
|
|
Concept
|
Protein Kinase Inhibitors
|
|
Concept
|
Proto-Oncogene Proteins c-akt
|
|
Concept
|
Proton Pump Inhibitors
|
|
Concept
|
Medication Adherence
|
|
Concept
|
Molecular Dynamics Simulation
|
|
Concept
|
Drug Substitution
|
|
Concept
|
Musculoskeletal Pain
|
|
Academic Article
|
Concomitant amphotericin B therapy, granulocyte transfusions, and GM-CSF administration for disseminated infection with Fusarium in a granulocytopenic patient.
|
|
Academic Article
|
Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases.
|
|
Academic Article
|
Acute myeloid leukaemia following interferon-alfa treatment of hairy cell leukaemia.
|
|
Academic Article
|
Long-term outcome of patients with acute myelogenous leukemia: the role of maintenance therapy, consolidation therapy and the predictive value of two in vitro assays.
|
|
Academic Article
|
Biological characteristics of newly diagnosed poor prognosis acute myelogenous leukemia.
|
|
Academic Article
|
Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia.
|
|
Academic Article
|
Polymerase chain reaction-based diagnosis of del (5q) in acute myeloid leukemia and myelodysplastic syndrome identifies a minimal deletion interval.
|
|
Academic Article
|
Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases.
|
|
Academic Article
|
High-dose cladribine therapy for chronic myelogenous leukemia in the accelerated or blast phase.
|
|
Academic Article
|
The capacity to be alone as a stress buffer.
|
|
Academic Article
|
The selective use of AMSA following high-dose cytarabine in patients with acute myeloid leukaemia in relapse: a Leukemia Intergroup study.
|
|
Academic Article
|
Familial myeloid leukemia associated with loss of the long arm of chromosome 5.
|
|
Academic Article
|
Myeloid leukemia after hematotoxins.
|
|
Academic Article
|
Phase I study of busulfan, cyclophosphamide, and timed sequential escalating doses of cytarabine followed by bone marrow transplantation.
|
|
Academic Article
|
Balanced translocations involving chromosome bands 11q23 and 21q22 in therapy-related leukemia.
|
|
Academic Article
|
High-energy total body irradiation as preparation for bone marrow transplantation in leukemia patients: treatment technique and related complications.
|
|
Academic Article
|
Refinement of the smallest commonly deleted segment of chromosome 20 in malignant myeloid diseases and development of a PAC-based physical and transcription map.
|
|
Academic Article
|
Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map.
|
|
Academic Article
|
Myeloid leukemia after cytotoxic therapy and other hematotoxins.
|
|
Academic Article
|
Prevalence of the inactivating 609C-->T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia.
|
|
Academic Article
|
Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse.
|
|
Academic Article
|
dic(5;17): a recurring abnormality in malignant myeloid disorders associated with mutations of TP53.
|
|
Academic Article
|
CBFA2(AML1) translocations with novel partner chromosomes in myeloid leukemias: association with prior therapy.
|
|
Academic Article
|
Detection of trisomy 12 in chronic lymphocytic leukemia by fluorescence in situ hybridization to interphase cells: a simple and sensitive method.
|
|
Academic Article
|
Impact of azacytidine on the quality of life of patients with myelodysplastic syndrome treated in a randomized phase III trial: a Cancer and Leukemia Group B study.
|
|
Academic Article
|
Transcript map and comparative analysis of the 1.5-Mb commonly deleted segment of human 5q31 in malignant myeloid diseases with a del(5q).
|
|
Academic Article
|
Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated intergroup study.
|
|
Academic Article
|
Preliminary experience with a new chemotherapy regimen for adults with acute lymphoblastic leukemia.
|
|
Academic Article
|
Is modulation of multidrug resistance a viable strategy for acute myeloid leukemia?
|
|
Academic Article
|
Interleukin-1 beta expression and treatment outcome in acute myelogenous leukemia.
|
|
Academic Article
|
t(1;3)(p36;p21) is a recurring therapy-related translocation.
|
|
Academic Article
|
Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.
|
|
Academic Article
|
Elitek-rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002.
|
|
Academic Article
|
Acute lymphoblastic leukaemia: diagnosis and classification.
|
|
Academic Article
|
Polymorphisms in the MLL breakpoint cluster region (BCR).
|
|
Academic Article
|
Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia.
|
|
Academic Article
|
Additional cytogenetic abnormalities in adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a study of the Cancer and Leukaemia Group B.
|
|
Academic Article
|
Adult de novo acute myeloid leukemia with t(6;11)(q27;q23): results from Cancer and Leukemia Group B Study 8461 and review of the literature.
|
|
Academic Article
|
Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): results from CALGB 8461.
|
|
Academic Article
|
Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: final results of Cancer and Leukemia Group B Study 9251.
|
|
Academic Article
|
A phase I trial of gemcitabine plus cladribine in patients with advanced hematologic malignant diseases.
|
|
Academic Article
|
Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series.
|
|
Academic Article
|
Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study.
|
|
Academic Article
|
Treatment of the chronic phase of chronic myeloid leukemia with an intermittent schedule of recombinant interferon alfa-2b and cytarabine: results from CALGB study 9013.
|
|
Academic Article
|
Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study.
|
|
Academic Article
|
Pharmacokinetics, pharmacodynamics and adherence to oral topotecan in myelodysplastic syndromes: a Cancer and Leukemia Group B study.
|
|
Academic Article
|
Quality of life in patients with newly diagnosed chronic phase chronic myeloid leukemia on imatinib versus interferon alfa plus low-dose cytarabine: results from the IRIS Study.
|
|
Academic Article
|
Management of acute lymphoblastic leukemia in older patients.
|
|
Academic Article
|
A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare 'poor prognosis' myeloid malignancies.
|
|
Academic Article
|
Trisomy 6: a recurring cytogenetic abnormality associated with marrow hypoplasia.
|
|
Academic Article
|
Therapy-related myeloid leukaemia: a model for leukemogenesis in humans.
|
|
Academic Article
|
Myelodysplasia: when to treat and how.
|
|
Academic Article
|
Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia.
|
|
Academic Article
|
Gene expression profiles in acute myeloid leukemia with common translocations using SAGE.
|
|
Academic Article
|
Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication: a Cancer and Leukemia Group B study.
|
|
Academic Article
|
Deletions of interferon genes in acute lymphoblastic leukemia.
|
|
Academic Article
|
Successful autologous stem cell collection in patients with chronic myeloid leukemia in complete cytogenetic response, with quantitative measurement of BCR-ABL expression in blood, marrow, and apheresis products.
|
|
Academic Article
|
High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study.
|
|
Academic Article
|
Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011.
|
|
Academic Article
|
Low-dose interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720.
|
|
Academic Article
|
Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia.
|
|
Academic Article
|
Etiology and management of therapy-related myeloid leukemia.
|
|
Academic Article
|
Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation.
|
|
Academic Article
|
Therapy-related myeloid leukemia.
|
|
Academic Article
|
Multiple unrelated clonal abnormalities in host bone marrow cells after allogeneic stem cell transplantation.
|
|
Academic Article
|
Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Group B Study 9621.
|
|
Academic Article
|
An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia.
|
|
Academic Article
|
Clinical, morphologic, and cytogenetic characteristics of patients with lymphoid malignancies characterized by both t(14;18)(q32;q21) and t(8;14)(q24;q32) or t(8;22)(q24;q11).
|
|
Academic Article
|
MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia.
|
|
Academic Article
|
Distinct microRNA expression profiles in acute myeloid leukemia with common translocations.
|
|
Academic Article
|
Irreversible myelosuppression after fludarabine-melphalan conditioning: observations in patients with graft rejection.
|
|
Academic Article
|
Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha: a Cancer and Leukemia Group B study.
|
|
Academic Article
|
Discontinuing imatinib in chronic myeloid leukemia: don't try this at home.
|
|
Academic Article
|
Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.
|
|
Academic Article
|
Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study.
|
|
Academic Article
|
Allogeneic stem cell transplantation with alemtuzumab-based conditioning for patients with advanced chronic myelogenous leukemia.
|
|
Academic Article
|
Safety and efficacy of romiplostim in patients with lower-risk myelodysplastic syndrome and thrombocytopenia.
|
|
Academic Article
|
Treatment of relapsed chronic lymphocytic leukemia by 72-hour continuous infusion or 1-hour bolus infusion of flavopiridol: results from Cancer and Leukemia Group B study 19805.
|
|
Academic Article
|
Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study.
|
|
Academic Article
|
The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma.
|
|
Academic Article
|
Therapy-related myeloid neoplasms.
|
|
Academic Article
|
Acute lymphoblastic leukemia: older patients and newer drugs.
|
|
Academic Article
|
Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive disease.
|
|
Academic Article
|
Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase.
|
|
Academic Article
|
Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801.
|
|
Academic Article
|
Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence.
|
|
Academic Article
|
Treatment of therapy-related myeloid neoplasms with high-dose cytarabine/mitoxantrone followed by hematopoietic stem cell transplant.
|
|
Academic Article
|
Cardiac tamponade in a patient with chronic lymphocytic leukemia.
|
|
Academic Article
|
BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
|
|
Academic Article
|
Clinicopathologic manifestations and breakpoints of the t(3;5) in patients with acute nonlymphocytic leukemia.
|
|
Academic Article
|
Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine: a Cancer and Leukemia Group B study.
|
|
Academic Article
|
Successful allogeneic transplantation of patients with suspected prior invasive mold infection.
|
|
Academic Article
|
High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk acute myeloid leukemia (AML).
|
|
Academic Article
|
Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions.
|
|
Academic Article
|
Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet.
|
|
Academic Article
|
Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial.
|
|
Academic Article
|
A randomized trial of dasatinib 100 mg versus imatinib 400 mg in newly diagnosed chronic-phase chronic myeloid leukemia.
|
|
Academic Article
|
MiR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia.
|
|
Academic Article
|
CML: live long and prosper.
|
|
Academic Article
|
miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia.
|
|
Academic Article
|
Low expression of MN1 associates with better treatment response in older patients with de novo cytogenetically normal acute myeloid leukemia.
|
|
Academic Article
|
Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes.
|
|
Academic Article
|
Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t(16;16) has a favorable prognosis.
|
|
Academic Article
|
Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II.
|
|
Academic Article
|
Low O6-alkylguanine DNA alkyltransferase activity in the peripheral blood lymphocytes of patients with therapy-related acute nonlymphocytic leukemia.
|
|
Academic Article
|
Fludarabine followed by alemtuzumab consolidation for previously untreated chronic lymphocytic leukemia: final report of Cancer and Leukemia Group B study 19901.
|
|
Academic Article
|
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.
|
|
Academic Article
|
IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
|
|
Academic Article
|
Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia.
|
|
Academic Article
|
Consolidation therapy with subcutaneous alemtuzumab after fludarabine and rituximab induction therapy for previously untreated chronic lymphocytic leukemia: final analysis of CALGB 10101.
|
|
Academic Article
|
Concurrent use of proton pump inhibitors or H2 blockers did not adversely affect nilotinib efficacy in patients with chronic myeloid leukemia.
|
|
Academic Article
|
A morphologic and cytochemical study of acute myelomonocytic leukemia with abnormal marrow eosinophils associated with inv(16)(p13q22).
|
|
Academic Article
|
Association of a chromosomal 3;21 translocation with the blast phase of chronic myelogenous leukemia.
|
|
Academic Article
|
Assignment of the GM-CSF, CSF-1, and FMS genes to human chromosome 5 provides evidence for linkage of a family of genes regulating hematopoiesis and for their involvement in the deletion (5q) in myeloid disorders.
|
|
Academic Article
|
Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia.
|
|
Academic Article
|
Variations of the ataxia telangiectasia mutated gene in patients with chronic lymphocytic leukemia lack substantial impact on progression-free survival and overall survival: a Cancer and Leukemia Group B study.
|
|
Academic Article
|
Der(5)t(5;7)(q11.2;p11.2): a new recurring abnormality in malignant myeloid disorders.
|
|
Academic Article
|
Acute myelomonocytic leukemia with abnormal eosinophils presenting as an ovarian mass: a report of two cases and a review of the literature.
|
|
Academic Article
|
Assignment of CSF-1 to 5q33.1: evidence for clustering of genes regulating hematopoiesis and for their involvement in the deletion of the long arm of chromosome 5 in myeloid disorders.
|
|
Academic Article
|
Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute leukemia.
|
|
Academic Article
|
Management of myelodysplastic syndromes.
|
|
Academic Article
|
Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity from chromosomes 5 and 7 in malignant myeloid disorders.
|
|
Academic Article
|
Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission.
|
|
Academic Article
|
Interleukin-4 and interleukin-5 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del(5q).
|
|
Academic Article
|
Rates of cholesterol biosynthesis are related to early differentiation in acute non-lymphocytic leukaemia cells.
|
|
Academic Article
|
Methyl transferase activity in secondary leukemia.
|
|
Academic Article
|
Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association.
|
|
Academic Article
|
Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511.
|
|
Academic Article
|
Current management of acute lymphoblastic leukemia in adults.
|
|
Academic Article
|
Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-associated leukemia.
|
|
Academic Article
|
Detection of MLL gene rearrangements in adult acute lymphoblastic leukemia. A Cancer and Leukemia Group B study.
|
|
Academic Article
|
Evidence for the involvement of GM-CSF and FMS in the deletion (5q) in myeloid disorders.
|
|
Academic Article
|
Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7.
|
|
Academic Article
|
Certain HLA antigens are associated with specific morphologic and cytogenetic subsets of acute myeloid leukemia.
|
|
Academic Article
|
Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study.
|
|
Academic Article
|
Feasibility of administering oblimersen (G3139; Genasense) with imatinib mesylate in patients with imatinib resistant chronic myeloid leukemia--Cancer and leukemia group B study 10107.
|
|
Academic Article
|
What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies.
|
|
Academic Article
|
Response to 5-azacytidine in patients with refractory acute nonlymphocytic leukemia and association with chromosome findings.
|
|
Academic Article
|
Mitoxantrone and 5-azacytidine for refractory/relapsed ANLL or CML in blast crisis: a leukemia intergroup study.
|
|
Academic Article
|
Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase.
|
|
Academic Article
|
Auto-SCT for AML in second remission: CALGB study 9620.
|
|
Academic Article
|
Genome-wide association study to identify novel loci associated with therapy-related myeloid leukemia susceptibility.
|
|
Academic Article
|
Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia.
|
|
Academic Article
|
Heterogeneity of O6-alkylguanine-DNA alkyltransferase activity in peripheral blood lymphocytes: relationship between this activity in lymphocytes and in lymphoblastoid lines from normal controls and from patients with Hodgkin's disease or non-Hodgkin's lymphoma.
|
|
Academic Article
|
Novel oncogenic mutations of CBL in human acute myeloid leukemia that activate growth and survival pathways depend on increased metabolism.
|
|
Academic Article
|
Cytogenetic clonality in myelodysplastic syndromes studied with fluorescence in situ hybridization: lineage, response to growth factor therapy, and clone expansion.
|
|
Academic Article
|
Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group.
|
|
Academic Article
|
Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
|
|
Academic Article
|
Chemoimmunotherapy with fludarabine and rituximab produces extended overall survival and progression-free survival in chronic lymphocytic leukemia: long-term follow-up of CALGB study 9712.
|
|
Academic Article
|
A recurring chromosome rearrangement, dic(16;22), in acute nonlymphocytic leukemia.
|
|
Academic Article
|
Chromosome changes in hematologic malignancies.
|
|
Academic Article
|
Acute leukemia in adults: recent developments in diagnosis and treatment.
|
|
Academic Article
|
Establishment of a leukemia cell line with i(12p) from a patient with a mediastinal germ cell tumor and acute lymphoblastic leukemia.
|
|
Academic Article
|
Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: a Cancer and Leukemia Group B Study.
|
|
Academic Article
|
Genomic DNA breakpoints in AML1/RUNX1 and ETO cluster with topoisomerase II DNA cleavage and DNase I hypersensitive sites in t(8;21) leukemia.
|
|
Academic Article
|
Balanced chromosome abnormalities inv(16) and t(15;17) in therapy-related myelodysplastic syndromes and acute leukemia: report from an international workshop.
|
|
Academic Article
|
Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.
|
|
Academic Article
|
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461).
|
|
Academic Article
|
RAS, FLT3, and TP53 mutations in therapy-related myeloid malignancies with abnormalities of chromosomes 5 and 7.
|
|
Academic Article
|
Core binding factor acute myeloid leukemia. Cancer and Leukemia Group B (CALGB) Study 8461.
|
|
Academic Article
|
Dose-ranging pharmacodynamic study of tipifarnib (R115777) in patients with relapsed and refractory hematologic malignancies.
|
|
Academic Article
|
Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome.
|
|
Academic Article
|
Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence.
|
|
Academic Article
|
Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justification for risk-adapted therapy.
|
|
Academic Article
|
High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study.
|
|
Academic Article
|
t(3;21)(q26;q22): a recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia.
|
|
Academic Article
|
Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study.
|
|
Academic Article
|
Therapy-related myeloid sarcoma with an NPM1 mutation.
|
|
Academic Article
|
FLT3 mutation status is a predictor of early death in pediatric acute promyelocytic leukemia: a report from the Children's Oncology Group.
|
|
Academic Article
|
High-performance liquid chromatographic assay for mitoxantrone in plasma using electrochemical detection.
|
|
Academic Article
|
Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma.
|
|
Academic Article
|
Studies of the human c-myb gene and its product in human acute leukemias.
|
|
Academic Article
|
Children and adolescents in a changing media world.
|
|
Academic Article
|
Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia.
|
|
Academic Article
|
A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia.
|
|
Academic Article
|
Impact of age on outcomes after initial therapy with chemotherapy and different chemoimmunotherapy regimens in patients with chronic lymphocytic leukemia: results of sequential cancer and leukemia group B studies.
|
|
Academic Article
|
Allogeneic hematopoietic cell transplantation for adults with ALL.
|
|
Academic Article
|
Immune reconstitution after combined haploidentical and umbilical cord blood transplant.
|
|
Academic Article
|
Current practices in the management of chronic myeloid leukemia.
|
|
Academic Article
|
Nilotinib in imatinib-resistant or imatinib-intolerant patients with chronic myeloid leukemia in chronic phase: 48-month follow-up results of a phase II study.
|
|
Academic Article
|
The impact of initial fludarabine therapy on transformation to Richter syndrome or prolymphocytic leukemia in patients with chronic lymphocytic leukemia: analysis of an intergroup trial (CALGB 9011).
|
|
Academic Article
|
The spectrum of somatic mutations in high-risk acute myeloid leukaemia with -7/del(7q).
|
|
Academic Article
|
Phase II study of the oral MEK inhibitor selumetinib in advanced acute myelogenous leukemia: a University of Chicago phase II consortium trial.
|
|
Academic Article
|
Fate of patients with newly diagnosed acute myeloid leukemia who fail primary induction therapy.
|
|
Academic Article
|
Patients with chronic lymphocytic leukemia with high-risk genomic features have inferior outcome on successive Cancer and Leukemia Group B trials with alemtuzumab consolidation: subgroup analysis from CALGB 19901 and CALGB 10101.
|
|
Academic Article
|
BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive leukemia.
|
|
Academic Article
|
Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia.
|
|
Academic Article
|
A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromes.
|
|
Academic Article
|
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study.
|
|
Academic Article
|
Outcome of adolescents and young adults with acute myeloid leukemia treated on COG trials compared to CALGB and SWOG trials.
|
|
Academic Article
|
Changing the cost of care for chronic myeloid leukemia: the availability of generic imatinib in the USA and the EU.
|
|
Academic Article
|
Final results of EFC6663: a multicenter, international, phase 2 study of alvocidib for patients with fludarabine-refractory chronic lymphocytic leukemia.
|
|
Academic Article
|
Imatinib 800 mg daily induces deeper molecular responses than imatinib 400 mg daily: results of SWOG S0325, an intergroup randomized PHASE II trial in newly diagnosed chronic phase chronic myeloid leukaemia.
|
|
Academic Article
|
Anorexia nervosa in the context of daily experience.
|
|
Academic Article
|
Safety and efficacy of switching to nilotinib 400 mg twice daily for patients with chronic myeloid leukemia in chronic phase with suboptimal response or failure on front-line imatinib or nilotinib 300 mg twice daily.
|
|
Academic Article
|
Simvastatin radiosensitizes differentiated and stem-like breast cancer cell lines and is associated with improved local control in inflammatory breast cancer patients treated with postmastectomy radiation.
|
|
Academic Article
|
Arsenic trioxide in front-line therapy of acute promyelocytic leukemia (C9710): prognostic significance of FLT3 mutations and complex karyotype.
|
|
Academic Article
|
Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy.
|
|
Academic Article
|
Oral Debio1143 (AT406), an antagonist of inhibitor of apoptosis proteins, combined with daunorubicin and cytarabine in patients with poor-risk acute myeloid leukemia--results of a phase I dose-escalation study.
|
|
Academic Article
|
Overexpression and knockout of miR-126 both promote leukemogenesis.
|
|
Academic Article
|
Cytogenetic prioritization with inclusion of molecular markers predicts outcome in previously untreated patients with chronic lymphocytic leukemia treated with fludarabine or fludarabine plus cyclophosphamide: a long-term follow-up study of the US intergroup phase III trial E2997.
|
|
Academic Article
|
Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502.
|
|
Academic Article
|
Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial.
|
|
Academic Article
|
Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.
|
|
Academic Article
|
Myeloid Leukemia After Cytotoxic Therapy and Other Hematotoxins.
|
|
Academic Article
|
Incidence and predictors of respiratory viral infections by multiplex PCR in allogeneic hematopoietic cell transplant recipients 50 years and older including geriatric assessment.
|
|
Academic Article
|
Eradication of Acute Myeloid Leukemia with FLT3 Ligand-Targeted miR-150 Nanoparticles.
|
|
Academic Article
|
Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665.
|
|
Academic Article
|
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.
|
|
Academic Article
|
Phase 1 dose-finding study of rebastinib (DCC-2036) in patients with relapsed chronic myeloid leukemia and acute myeloid leukemia.
|
|
Academic Article
|
Epidemiologic evidence on the relationship between mists containing sulfuric acid and respiratory tract cancer.
|
|
Academic Article
|
Efficacy of single-agent decitabine in relapsed and refractory acute myeloid leukemia.
|
|
Academic Article
|
Managing CNS disease in adults with acute lymphoblastic leukemia.
|
|
Academic Article
|
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation.
|
|
Academic Article
|
Mechanisms of citral phototoxicity.
|
|
Academic Article
|
Beta-carboline alkaloids: mechanisms of phototoxicity to bacteria and insects.
|
|
Academic Article
|
RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia.
|
|
Academic Article
|
Cu(II) sensitizes pBR322 plasmid DNA to inactivation by UV-B (280-315 nm).
|
|
Academic Article
|
Ferric-ion-photosensitized damage to DNA by hydroxyl and non-hydroxyl radical mechanisms.
|
|
Academic Article
|
Author Correction: RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia.
|
|
Academic Article
|
Surfactant-assisted UV-photolysis of nitroarenes.
|
|
Academic Article
|
Midostaurin: its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis.
|
|
Academic Article
|
Patients' perspectives on the definition of cure in chronic myeloid leukemia.
|
|
Academic Article
|
Transplantation in adults with relapsed/refractory acute lymphoblastic leukemia who are treated with blinatumomab from a phase 3 study.
|
|
Academic Article
|
Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomes.
|
|
Academic Article
|
Dose escalation prophylactic donor lymphocyte infusion after T-cell depleted matched related donor allogeneic hematopoietic cell transplantation is feasible and results in higher donor chimerism, faster immune re-constitution, and prolonged progression-free survival.
|
|
Academic Article
|
A phase 1 study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid leukemia.
|
|
Academic Article
|
Phase I trial of maintenance selinexor after allogeneic hematopoietic stem cell transplantation for patients with acute myeloid leukemia and myelodysplastic syndrome.
|
|
Academic Article
|
Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial.
|
|
Academic Article
|
Assessment of Outcomes After Stopping Tyrosine Kinase Inhibitors Among Patients With Chronic Myeloid Leukemia: A Nonrandomized Clinical Trial.
|
|
Academic Article
|
Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis.
|
|
Academic Article
|
Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemia.
|
|
Academic Article
|
Dasatinib and dexamethasone followed by hematopoietic cell transplantation for adults with Ph-positive ALL.
|
|
Academic Article
|
Therapy-related myeloid neoplasms in 109 patients after radiation monotherapy.
|
|
Academic Article
|
Therapeutic drug monitoring in oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology consensus guidelines for imatinib therapy.
|
|
Academic Article
|
Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplications.
|
|
Academic Article
|
Inequities in Alliance Acute Leukemia Clinical Trial and Biobank Participation: Defining Targets for Intervention.
|
|
Academic Article
|
High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML.
|
|
Academic Article
|
Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemia.
|
|
Academic Article
|
Efficacy and tolerability of a modified pediatric-inspired intensive regimen for acute lymphoblastic leukemia in older adults.
|
|
Academic Article
|
Inherited cancer predisposing mutations in patients with therapy-related myeloid neoplasms.
|
|
Academic Article
|
Asciminib monotherapy for newly diagnosed chronic myeloid leukemia in chronic phase: the ASC4FIRST phase III trial.
|
|
Concept
|
Clinical Decision-Making
|
|
Concept
|
Imatinib Mesylate
|
|
Concept
|
Rituximab
|
|
Concept
|
Filgrastim
|
|
Concept
|
Bortezomib
|
|
Concept
|
Bendamustine Hydrochloride
|
|
Concept
|
Patient Reported Outcome Measures
|
|
Concept
|
Pharmacogenomic Variants
|
|
Concept
|
Pharmacogenomic Testing
|
|
Concept
|
Alpha-Ketoglutarate-Dependent Dioxygenase FTO
|
|
Concept
|
Positron Emission Tomography Computed Tomography
|
|
Concept
|
MDS1 and EVI1 Complex Locus Protein
|
|
Concept
|
CD52 Antigen
|
|
Concept
|
Myeloid Ecotropic Viral Integration Site 1 Protein
|
|
Concept
|
RUNX1 Translocation Partner 1 Protein
|
|
Concept
|
Alemtuzumab
|
|
Concept
|
Health Impact Assessment
|
|
Concept
|
Pediatric Obesity
|
|
Concept
|
Sialic Acid Binding Ig-like Lectin 3
|
|
Concept
|
Apc8 Subunit, Anaphase-Promoting Complex-Cyclosome
|
|
Concept
|
Triple Negative Breast Neoplasms
|
|
Concept
|
Historically Controlled Study
|
|
Concept
|
Social Determinants of Health
|
|
Concept
|
In Vitro Techniques
|
|
Academic Article
|
Association of social deprivation with survival in younger adult patients with AML: an Alliance study.
|
|
Academic Article
|
Tolerability and Efficacy of the Anticluster of Differentiation 47 Antibody Magrolimab Combined With Azacitidine in Patients With Previously Untreated AML: Phase Ib Results.
|
|
Academic Article
|
A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML.
|
|
Academic Article
|
Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG).
|